menu

LEMTRADA is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS). Because of its risks, LEMTRADA is generally used in people who have tried 2 or more MS medicines that have not worked well enough. It is not known if LEMTRADA is safe and effective for use in children under 17 years of age.

View IMPORTANT SAFETY INFORMATION

Tackling My Relapsing MS Head-On LEMTRADA patient blogger: Donnie By Donnie, Father, Husband, Project Leader, Former Athlete • December 7, 2016

LEMTRADA® patient, Donnie, and his family

I remember when it happened—when relapsing MS showed up uninvited, but I processed the news, and I approached my diagnosis the same way I approach everything in life. I decided to tackle my MS head-on with a positive approach and a never-quit philosophy. So what if I have this disease? MS can’t control my faith or my attitude. I control those things.

I started therapy within weeks of my diagnosis. I tried injectables, IV treatments—all sorts of other therapies—but stopped all of them for one reason or the other.

In 2011 my neurologist told me about LEMTRADA. It was still in clinical trials, so we decided to wait for approval and then consider it. My doctor and I talked about the clinical trial results, as well as the possible side effects. After we had that discussion, I was sold.

My previous RMS medications didn’t work well enough for me. I was getting worse. I understood the importance of getting on a medication that slows down disability progression, so I was willing to try something else. My wife and I discussed the decision to start LEMTRADA, and she was all in.

When the drug was approved in 2014, I was ready to go. I was the first person in my state to enroll in the MS One to One® program for LEMTRADA. Additionally, before my first round of infusions, my wife and I met with a nurse at my neurologist’s office to go over the infusion process. Of course, she had lots of information to cover. She explained all of the potential side effects, what to expect during the infusions, and the lab tests and skin exam I would need to take.

LEMTRADA has worked well for me, but every patient is different, so I would encourage anyone who is considering LEMTRADA to work with your healthcare provider. Personally, LEMTRADA was the right choice for me.

  • CLINICAL TRIALS
  • DIAGNOSIS
  • MS ONE TO ONE
  • THE DECISION
  • TREATMENT



Related Posts

MY LIFE

Living with RMS on My Own Terms

By Donnie, Father, Husband, Project Leader, Former Athlete, February 16, 2017

I’m going to start this post with a quote that I try to live my life by every day: “Our lives are not determined by what happens

MY DECISION

A Moment to Remember: Choosing LEMTRADA

By Katy, Wife, Writer, and Yoga Instructor, January 9, 2017

When I was diagnosed with relapsing multiple sclerosis at 19 years old, I was terrified, to say the least

0 Comments

Add a comment

All fields required




1000 characters remaining

By clicking the Submit button you are agreeing to our Terms of Use. All submissions must be approved by Sanofi Genzyme before they will be posted.

The information on this page is owned and controlled by Sanofi Genzyme. All submissions will be reviewed and must be approved by Sanofi Genzyme before being posted. Comments that do not directly relate to the topic, potentially violate US FDA regulations, are factually inaccurate or misleading, or are spam, inappropriate, defamatory or use profanity will not be posted.

Please keep your comments respectful and appropriate, and do not reference any product names or product information. We will not post comments that include drug names or descriptions. Please note that Sanofi Genzyme may choose not to post, or may remove, a comment for any reason at any time. Comments on the page from members of the public do not necessarily reflect the views of Sanofi Genzyme, and Sanofi Genzyme does not endorse any content added by other users.

We are required to record and handle the submitted comments in a specific manner to monitor the safety of our product. If you have experienced a side effect or have a complaint specific to a Sanofi Genzyme product, please contact your healthcare provider. In addition, we encourage you to report the event to us by calling Sanofi Genzyme at 800-745-4447, where someone is available to speak with you.

The information on this page is intended for U.S. residents only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns.

Blog Terms of Use

LEMTRADA Events

Attend a live event or watch one online to learn more about LEMTRADA.


More From this Blogger

  • Passing the Time: My Infusion Experience

    January 23, 2017

    Spending 8 hours in the infusion center makes for a long day! Infusions take about 4 hours—and ...

  • Meeting My Teammates —MS One to One®

    December 15, 2016

    LEMTRADA was approved on November 14, 2014, in the US. How do I know this date so well? Because I ha ...

  • Perfection to Progression: My RMS Diagnosis

    December 6, 2016

    When it comes to my life, I’ve always been batting a thousand. Spending time with my family is ...


Tags

Show Less
  • FAMILY
  • PATIENT
  • YEAR 1
  • DIAGNOSIS
  • THE DECISION
  • SUPPORT
  • TREATMENT
  • NURSE
  • CARE PARTNER
  • LIVING WITH RELAPSING MS
  • CLINICAL TRIALS
  • INFUSION PREP
  • SYMPTOMS
  • HOBBIES
  • MS ONE TO ONE
  • CHILDREN
  • NEUROLOGIST
  • EDUCATION
  • EDUCATION
  • DISABILITY PROGRESSION
  • HEALTHCARE PROVIDER
  • EXERCISE
  • TIPS
  • RELATIONSHIPS
  • SIDE EFFECTS
  • RELAPSE
  • RESOURCES
  • INFUSION
  • POST-INFUSION
  • MONITORING
  • HOPE
  • COMMUNITY
  • FRIENDS
  • YEAR 2
  • GOALS
  • CAREER
  • FINANCE
  • VOLUNTEER
  • EVENTS
  • HOPE
  • NUTRITION
  • HOLIDAYS
  • RESULTS
  • RELAPSING MS
  • DECISION-MAKING
  • COMMUNICATION
  • SELF-ADVOCACY
  • MAKING A SWITCH
  • DECISION